7 December 2009 | Gardasil has received a tick of approval from the Therapeutic Goods Administration, with the drug regulator confirming a "very low" number of adverse events from the human papillomavirus vaccine.
6 November 2009 | Government spending on preventive health and promotion jumped by 21 per cent during the 2007-08 financial year, driven by the roll out of the human papilloma virus vaccination program to fight cervical cancer.
4 December 2007 | Leading experts have dismissed suggestions of safety fears associated with cervical cancer vaccine Gardasil.